Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

9.72
+0.17001.78%
Post-market: 9.750.0300+0.31%19:30 EDT
Volume:1.48M
Turnover:14.34M
Market Cap:2.18B
PE:13.88
High:9.76
Open:9.56
Low:9.52
Close:9.55
52wk High:20.46
52wk Low:7.21
Shares:223.98M
Float Shares:210.51M
Volume Ratio:0.76
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7004
EPS(LYR):0.6000
ROE:41.90%
ROA:21.78%
PB:5.33
PE(LYR):16.20

Loading ...

May 02, 2023

Major Issues Report

8-K - Current report
Mar 23, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 23, 2023

Major Issues Report

8-K - Current report
Mar 10, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Major Issues Report

8-K - Current report
Jan 17, 2023

Major Issues Report

8-K - Current report
Dec 09, 2022

Major Issues Report

8-K - Current report
Dec 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 07, 2022

Major Issues Report

8-K - Current report
Dec 06, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 31, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Major Issues Report

8-K - Current report
Aug 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]